Related references
Note: Only part of the references are listed.Unusual presentation of upper urinary tract urothelial carcinoma in Taiwan: Direct comparison from Taiwan-Japan UTUC Collaboration Cohort
Hao Lun Luo et al.
INTERNATIONAL JOURNAL OF UROLOGY (2020)
Mutational signatures are jointly shaped by DNA damage and repair
Nadezda V. Volkova et al.
NATURE COMMUNICATIONS (2020)
Pig-a gene mutation assay study design: critical assessment of 3-versus 28-day repeat-dose treatment schedules
Azeddine Elhajouji et al.
MUTAGENESIS (2020)
In Vivo Metabolism of Aristolochic Acid I and II in Rats Is Influenced by Their Coexposure
Alena Dedikova et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2020)
A Compendium of Mutational Signatures of Environmental Agents
Jill E. Kucab et al.
CELL (2019)
Balkan Endemic Nephropathy and the Causative Role of Aristolochic Acid
Bojan Jelakovic et al.
SEMINARS IN NEPHROLOGY (2019)
Prognosis and risk factors of patients with upper urinary tract urothelial carcinoma and postoperative recurrence of bladder cancer in central China
Qingwei Wang et al.
BMC UROLOGY (2019)
Genome-wide somatic mutation analysis via Hawk-Seq™ reveals mutation profiles associated with chemical mutagens
Shoji Matsumura et al.
ARCHIVES OF TOXICOLOGY (2019)
The impact of p53 on aristolochic acid I-induced nephrotoxicity and DNA damage in vivo and in vitro
Mateja Sborchia et al.
ARCHIVES OF TOXICOLOGY (2019)
Herbal medicine containing aristolochic acid and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection
Chi-Jen Chen et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Update of aristolochic acid nephropathy in Korea
Tae Hyun Ban et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2018)
Impact of genetic modulation of SULT1A enzymes on DNA adduct formation by aristolochic acids and 3-nitrobenzanthrone
Volker M. Arlt et al.
ARCHIVES OF TOXICOLOGY (2017)
Comparison of the oxidation of carcinogenic aristolochic acid I and II by microsomal cytochromes P450 in vitro: experimental and theoretical approaches
Vaclav Martinek et al.
MONATSHEFTE FUR CHEMIE (2017)
Impact of aristolochic acid exposure on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy
Wenlong Zhong et al.
ONCOTARGETS AND THERAPY (2017)
Metabolic activation of 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine and DNA adduct formation depends on p53: Studies in Trp53(+/+), Trp53(+/-) and Trp53(-/-) mice
Annette M. Krais et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
LC-MS- and 1H NMR-Based Metabolomic Analysis and in Vitro Toxicological Assessment of 43 Aristolochia Species
Johanna Michl et al.
JOURNAL OF NATURAL PRODUCTS (2016)
Balkan endemic nephropathy: an update on its aetiology
Marie Stiborova et al.
ARCHIVES OF TOXICOLOGY (2016)
Aristolochic Acid in the Etiology of Renal Cell Carcinoma
Margaret L. Hoang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2016)
Induction of cytochromes P450 1A1 and 1A2 suppresses formation of DNA adducts by carcinogenic aristolochic acid I in rats in vivo
Helena Dracinska et al.
TOXICOLOGY (2016)
Recurrence pattern and TP53 mutation in upper urinary tract urothelial carcinoma
Chung-Hsin Chen et al.
ONCOTARGET (2016)
Omeprazole Alleviates Aristolochia manshuriensis Kom-Induced Acute Nephrotoxicity
Lianmei Wang et al.
PLOS ONE (2016)
Active Site Mutations as a Suitable Tool Contributing to Explain a Mechanism of Aristolochic Acid I Nitroreduction by Cytochromes P450 1A1, 1A2 and 1B1
Jan Milichovsky et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Induction of NAD(P)H:Quinone Oxidoreductase 1 (NQO1) by Glycyrrhiza Species Used for Women's Health: Differential Effects of the Michael Acceptors Isoliquiritigenin and Licochalcone A
Atieh Hajirahimkhan et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2015)
A Mechanism of O-Demethylation of Aristolochic Acid I by Cytochromes P450 and Their Contributions to This Reaction in Human and Rat Livers: Experimental and Theoretical Approaches
Marie Stiborova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
The genome as a record of environmental exposure
Serena Nik-Zainal et al.
MUTAGENESIS (2015)
Mutation signatures implicate aristolochic acid in bladder cancer development
Song Ling Poon et al.
GENOME MEDICINE (2015)
The influence of ochratoxin A on DNA adduct formation by the carcinogen aristolochic acid in rats
Marie Stiborova et al.
ARCHIVES OF TOXICOLOGY (2015)
Aristolochic acid-induced apoptosis and G2 cell cycle arrest depends on ROS generation and MAP kinases activation
Victor Romanov et al.
ARCHIVES OF TOXICOLOGY (2015)
Role of hepatic cytochrome P450 enzymes in the detoxication of aristolochic acid I; effects on DNA adduct, mutation, and tumor formation
Yang Luan et al.
GENES AND ENVIRONMENT (2015)
Exceptionally long- term persistence of DNA adducts formed by carcinogenic aristolochic acid I in renal tissue from patients with aristolochic acid nephropathy
Heinz H. Schmeiser et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Mechanisms of Enzyme-Catalyzed Reduction of Two Carcinogenic Nitro-Aromatics, 3-Nitrobenzanthrone and Aristolochic Acid I: Experimental and Theoretical Approaches
Marie Stiborova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
The influence of dicoumarol on the bioactivation of the carcinogen aristolochic acid I in rats
Marie Stiborova et al.
MUTAGENESIS (2014)
The effect of aristolochic acid I on expression of NAD(P)H:quinone oxidoreductase in mice and rats-A comparative study
Frantisek Barta et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2014)
Knockout and humanized mice as suitable tools to identify enzymes metabolizing the human carcinogen aristolochic acid
Marie Stiborova et al.
XENOBIOTICA (2014)
The Epidemiology, Diagnosis, and Management of Aristolochic Acid Nephropathy A Narrative Review
M. Refik Goekmen et al.
ANNALS OF INTERNAL MEDICINE (2013)
The aryl hydrocarbon receptor interacts with nuclear factor erythroid 2-related factor 2 to mediate induction of NAD(P)H: quinoneoxidoreductase 1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin
Liping Wang et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2013)
Induced Expression of Cytochrome P450 1A and NAD(P)H:Quinone Oxidoreductase Determined at mRNA, Protein, and Enzyme Activity Levels in Rats Exposed to the Carcinogenic Azo Dye 1-Phenylazo-2-naphthol (Sudan I)
Marie Stiborova et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2013)
Enzymes Metabolizing Aristolochic Acid and their Contribution to the Development of Aristolochic Acid Nephropathy and Urothelial Cancer
Marie Stiborova et al.
CURRENT DRUG METABOLISM (2013)
Aristolochic acid nephropathy: Harbinger of a global iatrogenic disease
Arthur P. Grollman
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2013)
Genome-Wide Mutational Signatures of Aristolochic Acid and Its Application as a Screening Tool
Song Ling Poon et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Mutational Signature of Aristolochic Acid Exposure as Revealed by Whole-Exome Sequencing
Margaret L. Hoang et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Evidence of exposure to aristolochic acid in patients with urothelial cancer from a Balkan endemic nephropathy region of Romania
Heinz H. Schmeiser et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2012)
Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid
Bojan Jelakovic et al.
KIDNEY INTERNATIONAL (2012)
Comparison of the mutagenicity of aristolochic acid I and aristolochic acid II in the gpt delta transgenic mouse kidney
Guozhen Xing et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2012)
Aristolochic acid-associated urothelial cancer in Taiwan
Chung-Hsin Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Bioactivation versus Detoxication of the Urothelial Carcinogen Aristolochic Acid I by Human Cytochrome P450 1A1 and 1A2
Marie Stiborova et al.
TOXICOLOGICAL SCIENCES (2012)
NAD(P)H:quinone oxidoreductase expression in Cyp1a-knockout and CYP1A-humanized mouse lines and its effect on bioactivation of the carcinogen aristolochic acid I
Katerina Levova et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2012)
Rosuvastatin suppresses the liver microsomal CYP2C11 and CYP2C6 expression in male Wistar rats
Alice Zacharova et al.
XENOBIOTICA (2012)
Conformational changes of the NADPH-dependent cytochrome P450 reductase in the course of electron transfer to cytochromes P450
Tomas Laursen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2011)
Fenofibrate-induced decrease of expression of CYP2C11 and CYP2C6 in rat
Rostislav Vecera et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2011)
Role of P450 1A1 and P450 1A2 in Bioactivation versus Detoxication of the Renal Carcinogen Aristolochic Acid I: Studies in Cyp1a1(-/-), Cyp1a2(-/-), and Cyp1a1/1a2(-/-) Mice
Volker M. Arlt et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2011)
Effect of neuroleptics on cytochrome P450 2C11 (CYP2C11) in rat liver
Anna Haduch et al.
PHARMACOLOGICAL REPORTS (2011)
Role of Cytochromes P450 1A1/2 in Detoxication and Activation of Carcinogenic Aristolochic Acid I: Studies with the Hepatic NADPH:Cytochrome P450 Reductase Null (HRN) Mouse Model
Katerina Levova et al.
TOXICOLOGICAL SCIENCES (2011)
Inhibition of Renal NQO1 Activity by Dicoumarol Suppresses Nitroreduction of Aristolochic Acid I and Attenuates its Nephrotoxicity
Min Chen et al.
TOXICOLOGICAL SCIENCES (2011)
Aristolochic acid I induced oxidative DNA damage associated with glutathione depletion and ERK1/2 activation in human cells
Feng-Yih Yu et al.
TOXICOLOGY IN VITRO (2011)
Coupled Motions Direct Electrons along Human Microsomal P450 Chains
Christopher R. Pudney et al.
PLOS BIOLOGY (2011)
NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector
Albena T. Dinkova-Kostova et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2010)
Cytochrome P450 1A2 Detoxicates Aristolochic Acid in the Mouse
Thomas A. Rosenquist et al.
DRUG METABOLISM AND DISPOSITION (2010)
Local uses of Aristolochia species and content of nephrotoxic aristolochic acid 1 and 2-A global assessment based on bibliographic sources
Michael Heinrich et al.
JOURNAL OF ETHNOPHARMACOLOGY (2009)
Short-term toxicity of aristolochic acid, aristolochic acid-I and aristolochic acid-II in rats
Yen-Hung Yeh et al.
FOOD AND CHEMICAL TOXICOLOGY (2008)
Hepatic cytochrome P450s metabolize aristolochic acid and reduce its kidney toxicity
Y Xiao et al.
KIDNEY INTERNATIONAL (2008)
Biotransformation enzymes in development of renal injury and urothelial cancer caused by aristolochic acid
M. Stiborova et al.
KIDNEY INTERNATIONAL (2008)
Aristolochic acid nephropathy: A worldwide problem
Frederic D. Debelle et al.
KIDNEY INTERNATIONAL (2008)
Metabolic activation of carcinogenic aristolochic acid, a risk factor for Balkan endemic nephropathy
Marie Stiborova et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2008)
Induction of P450 1A by 3-methylcholanthrene protects mice from aristolochic acid-I-induced acute renal injury
Xiang Xue et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Aristolochic acid mutagenesis:: molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancer
Volker M. Arlt et al.
CARCINOGENESIS (2007)
Aristolochic acid and the etiology of endemic (Balkan) nephropathy
Arthur P. Grollman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Selective toxicity of aristolochic acids I and II
Shinya Shibutani et al.
DRUG METABOLISM AND DISPOSITION (2007)
Rat cytochrome P4502C11 in liver microsomes involved in oxidation of anesthetic agent propofol and deactivated by prior treatment with propofol
Hiroshi Yamazaki et al.
DRUG METABOLISM AND DISPOSITION (2006)
Identification of a genotoxic mechanism for the carcinogenicity of the environmental pollutant and suspected human carcinogen o-anisidine
M Stiborová et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Human hepatic and renal microsomes, Cytochromes P450 1A1/2, NADPH:Cytochrome P450 reductase and prostaglandin H synthase mediate the formation of aristolochic acid-DNA adducts found in patients with urothelial cancer
M Stiborová et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
DNA adducts and p53 mutations in a patient with aristolochic acid-associated nephropathy
GM Lord et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2004)
Quinone reductases multitasking in the metabolic world
D Ross
DRUG METABOLISM REVIEWS (2004)
Human cytosolic enzymes involved in the metabolic activation of carcinogenic aristolochic acid:: evidence for reductive activation by human NAD(P)H:quinone oxidoreductase
M Stiborová et al.
CARCINOGENESIS (2003)
Rat microsomes activating the anticancer drug ellipticine to species covalently binding to deoxyguanosine in DNA are a suitable model mimicking ellipticine bioactivation in humans
M Stiborova et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2003)
Naturally occurring aristolactams, aristolochic acids and dioxoaporphines and their biological activities
V Kumar et al.
NATURAL PRODUCT REPORTS (2003)
Aristolochic acid a risk factor for Balkan endemic nephropathy-associated urothelial cancer?
VM Arlt et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Aristolochic acid as a probable human cancer hazard in herbal remedies: a review
VM Arlt et al.
MUTAGENESIS (2002)
Carcinogenic aristolochic acids upon activation by DT-diaphorase form adducts found in DNA of patients with Chinese herbs nephropathy
M Stiborová et al.
CARCINOGENESIS (2002)
Substrate specificity for rat cytochrome P450 (CYP) isoforms: screening with cDNA-expressed systems of the rat
K Kobayashi et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Human enzymes involved in the metabolic activation of carcinogenic aristolochic acids:: Evidence for reductive activation by cytochromes P450 1A1 and 1A2
M Stiborová et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2001)
Analyses of DNA adducts formed by ochratoxin A and aristolochic acid in patients with Chinese herbs nephropathy
VM Arlt et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2001)
Evidence for reductive activation of carcinogenic aristolochic acids by prostaglandin H synthase -: 32P-postlabeling analysis of DNA adduct formation
M Stiborová et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2001)
Regulation of genes encoding NAD(P)H:quinone oxidoreductases
AK Jaiswal
FREE RADICAL BIOLOGY AND MEDICINE (2000)
Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi).
JL Nortier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
